Redcare Pharmacy

Olaf Heinrich will step down as CEO of Redcare Pharmacy on 1 October after just over three years. The supervisory board proposes its current member Peter Schmid von Linstow as his successor; the vote is to be held at an extraordinary general meeting on 14 October. The supervisory board emphasizes that the change ensures continuity of strategy and builds on the regulatory foundations Heinrich established, such as the introduction of the e‑prescription. Investors reacted negatively; the share fell about two percent intraday. » Więcej na deraktionaer.de

Redcare’s supervisory board has appointed Peter Schmid von Linstow as the new CEO effective 1 October. He succeeds Olaf Heinrich, who is stepping down after three years as CEO and will remain with the company in an advisory capacity. Schmid has been a supervisory board member since April 2026 and brings more than twenty years of leadership experience with digital platforms and marketplaces. The appointment will be submitted to shareholders for approval at an extraordinary general meeting on 14 October. » Więcej na de.investing.com

Jefferies raised the target price for Redcare Pharmacy from €83 to €97 and kept the rating at 'Buy'. Analyst Martin Comtesse adjusted estimates for the reporting season and names Redcare his new favorite among online pharmacies. Jefferies says Redcare delivered a strong first half of the year, beating expectations on growth, customer additions and profitability; Jefferies views management’s raised full-year targets as still conservative. The stock rose during XETRA trading by about 2.7 percent at one point to €63.70. » Więcej na finanzen.net